A Novel Combined Allogeneic and Autologous Cell Therapy for Meniscus Tissue Repair

Despite advanced surgical techniques, meniscus repair remains a significant clinical challenge due to high failure rates and chronic disability among young patients. This project aims to address this issue through a novel, one-stage cell therapy combining allogeneic adipose-derived mesenchymal stem cells and autologous meniscus cells to promote regeneration. This therapy builds on the researchers' pioneering work with a similar approach for cartilage injuries, which showed promising results in clinical trials. The anticipated outcome is a paradigm shift in meniscus injury management, significantly reducing long-term disability and improving quality of life for young patients.